APLN and muscular atrophy: In addition, treatment with apelin also decreased the expression of muscle RING‐finger protein 1 (MuRF‐1), a skeletal muscle atrophy‐related ubiquitin E3 ligase, compared with treatment with IS alone (Figure4C).